231 related articles for article (PubMed ID: 8606638)
1. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
Berti-Mattera L; Day N; Peterson RG; Eichberg J
Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
3. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
4. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
5. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
Sredy J; Flam BR; Sawicki DR
Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
[TBL] [Abstract][Full Text] [Related]
6. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P
J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
[TBL] [Abstract][Full Text] [Related]
7. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
[TBL] [Abstract][Full Text] [Related]
8. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
9. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
[TBL] [Abstract][Full Text] [Related]
10. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.
Cameron NE; Leonard MB; Ross IS; Whiting PH
Diabetologia; 1986 Mar; 29(3):168-74. PubMed ID: 3084324
[TBL] [Abstract][Full Text] [Related]
11. Effect of sorbinil and ascorbic acid on myo-inositol transport in cultured rat Schwann cells exposed to elevated extracellular glucose.
Karihaloo AK; Joshi K; Chopra JS
J Neurochem; 1997 Nov; 69(5):2011-8. PubMed ID: 9349546
[TBL] [Abstract][Full Text] [Related]
12. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
13. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
Obrosova IG; Fathallah L
Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
[TBL] [Abstract][Full Text] [Related]
16. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
Greene DA; Mackway AM
Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
[TBL] [Abstract][Full Text] [Related]
17. Localization and regulation of renal Na+/myo-inositol cotransporter in diabetic rats.
Wiese TJ; Matsushita K; Lowe WL; Stokes JB; Yorek MA
Kidney Int; 1996 Oct; 50(4):1202-11. PubMed ID: 8887279
[TBL] [Abstract][Full Text] [Related]
18. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
19. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
20. The influence of insulin and sorbinil on myoinositol uptake in peripheral nerve from normal and diabetic rats and a neuroblastoma cell line (N1E-115).
Dunlop ME; Hill MA; Larkins RG
Diabetes Res; 1988 Jun; 8(2):51-7. PubMed ID: 3147829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]